SCHEMBL16628108

SCHEMBL16628108

Bc1c(OC)ccnc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.40
PDE2A O00408 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PDE10A Q9Y233 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
GAA P10253 1/20 0.34
HASPIN Q8TF76 3/20 0.34
SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25957083 0.78 ALDH1A1 (0.39) ALDH1A1CCR1CCR5CCR8PDGFRB
SCHEMBL31278202 0.77 MAOA (0.42) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL4080571 0.77 MAOA (0.42) MAOAPDE2APDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL27652560 0.76 MAOA (0.46) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL31147147 0.76 MAOA (0.41) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL3979208 0.76 MAOA (0.50) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL24344928 0.74 MAOA (0.40) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL8198856 0.74 KDM4E (0.45) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL14353296 0.74 IKBKB (0.41) MAOAPDE2APDE4APDE4BPDE4C
SCHEMBL23624591 0.74 MAOA (0.40) MAOAPDE2APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015051043-A1 BIARYL ACYL-SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS AMGEN INC. (US) 2015-04-09 WO disclosed